Lior Nesher - Concepedia

Author

Lior Nesher

Ben-Gurion University of the Negev ORCID

Also Known As

Dimpy Shah, L. NESHER, L. Nesher, Lea Vargas, Lior Nesher, Nesher L, Nərgiz İsmayıllı

125

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Ben-Gurion University of the Negev Soroka Medical Center The University of Texas MD Anderson Cancer Center Rambam Health Care Campus Tel Aviv University

About

Lior Nesher is an author at Ben-Gurion University of the Negev specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	1K
2	Health Sciences	4	4	98
3	Education	1	1	11
4	Nursing	1	1	11
5	Public Health	1	1	194

Lior Nesher

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel Tal Brosh‐Nissimov, Efrat Orenbuch‐Harroch, Michal Chowers, Clinical Microbiology and Infection VaccinationVaccinologyBnt162b2 Vaccine BreakthroughVaccine DevelopmentMedicine	2021	363
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers Noam Shental, Shlomia Levy, Vered Wuvshet, Science Advances EpidemiologyPoint-of-care TestingCompressed SensingViral DiagnosticsMedicine	2020	194
Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy Lior Nesher, K. V. I. Rolston Clinical Infectious Diseases Bowel Wall ThickeningWidespread UseAntibioticsPathogenesisGastroenterology	2012	183
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections Dimpy P. Shah, Shashank S. Ghantoji, Ella Ariza‐Heredia, Blood	2014	152
Utility of the Enzyme-Linked Immunospot Interferon-γ–Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients Lior Nesher, Dimpy P. Shah, Ella Ariza‐Heredia, The Journal of Infectious Diseases Cmv MonitoringCytomegalovirus InfectionTransplantationImmunodeficienciesTransplantation Medicine	2016	75
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients Lynn El Haddad, Ella Ariza‐Heredia, Dimpy P. Shah, The Journal of Infectious Diseases	2018	68
Fecal colonization and infection with <i><scp>P</scp>seudomonas aeruginosa</i> in recipients of allogeneic hematopoietic stem cell transplantation Lior Nesher, K. V. I. Rolston, Dimpy P. Shah, Transplant Infectious Disease	2014	59
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study Tanya Babich, Pontus Nauclér, John Karlsson Valik, International Journal of Antimicrobial Agents Pseudomonas Aeruginosa BacteraemiaPathogenic MicrobiologyAntimicrobial SusceptibilityHealthcare-associated InfectionClinical Epidemiology	2019	55
Epidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests Lior Nesher, Christiane Hadi, Lucrecia Salazar, Epidemiology and Infection	2015	44
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study Tanya Babich, Pontus Nauclér, John Karlsson Valik, Clinical Infectious Diseases	2019	41

Page 1